Dianthus Therapeutics, Inc. /De/
DNTH
Revenue
924.00k
▼-249.00k▼-21.23%
12 Months ChangeAssets
368.96M
▼-13.50M▼-3.53%
3 Months ChangeLiabilities
10.74M
▲966.00k▲9.88%
3 Months ChangeFree Cash Flow
-10.53M
▲9.24M▲46.74%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-16
Form 8-K
ID: 0000950170-24-106820
2024-08-08
Form 10-Q
ID: 0000950170-24-093948
2024-08-08
Form 8-K
ID: 0000950170-24-093920
2024-06-06
Form 8-K
ID: 0000950170-24-069675
2024-05-28
Form 8-K
ID: 0000950170-24-065371
2024-05-09
Form 10-Q
ID: 0000950170-24-057022
2024-05-09
Form 8-K
ID: 0000950170-24-056925
2024-03-21
Form 8-K
ID: 0000950170-24-034667
2024-01-22
Form 8-K
ID: 0001193125-24-011681
2024-01-08
Form 8-K
ID: 0000950170-24-002707